Safety and Pharmacokinetics of Famciclovir Single 1500 mg Dose in Adolescents With Recurrent Herpes Labialis

NCT00878072 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

53

Enrollment

INDUSTRY

Sponsor class

Conditions

Herpes Labialis

Interventions

DRUG: Famciclovir

Sponsor

Novartis Pharmaceuticals